Belgium has decided to temporarily ban the use of Novo Nordisk's diabetes drug Ozempic as a weight loss treatment amid a shortage of the medicine, according to a royal decree published in the country's Official Gazette on Tuesday.
Source:www.reuters.com
Discussion
Join the conversation
Sign in to share your thoughts with the community.
Loading comments…